Le Lézard
Classified in: Business
Subjects: TNM, ACC

Special Redemption for Globalance on August 8, 2018


CALGARY, July 19, 2018 /CNW/ - Middlefield Limited (the "Manager"), the manager of Globalance Dividend Growers Corp. ("Globalance") wishes to remind investors of the special redemption (the "Special Redemption") prior to the upcoming merger of Globalance into MBN Corporation ("MBN").

Globalance shareholders who do not wish to participate in the Merger have the opportunity to sell their shares in the market or redeem them before the Merger occurs. To participate in the Special Redemption, shareholders are required to provide notice by 5:00 p.m. (Toronto time) on August 8, 2018.  Surrendered Globalance shares will be redeemed at a price equal to the net asset value per share on August 15, 2018 and will be paid by the Fund on or about August 22, 2018. The Merger will take place on or about August 29, 2018 (the date of completion being the "Effective Date"), with MBN being the continuing entity following the Merger. MBN shares do not have any monthly or annual redemption or retraction rights attached to them.

The Merger will be effected at an exchange ratio calculated as the net asset value per equity share of Globalance divided by the net asset value per equity share of MBN, determined as at the close of trading on the TSX on the business day immediately prior to the Effective Date. Pursuant to the Merger, MBN will assume the liabilities of Globalance and will issue equity shares of MBN in satisfaction of the purchase price for all of the property of Globalance. The Merger remains subject to the satisfaction of all regulatory requirements and customary closing conditions.  All costs and expenses associated with the Merger will be borne by the Manager and not the Funds.

Equity Shares of Globalance and MBN trade under the symbols GBF and MBN, respectively, on the Toronto Stock Exchange.

Certain statements in this press release may be viewed as forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, intentions, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects", "is expected", "anticipates", "plans", "estimates" or "intends" (or negative or grammatical variations thereof), or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements. Statements which may constitute forward-looking statements relate to: the proposed timing of the merger and expected completion thereof; the expected benefits of the merger; and the funds that are proposed to be merged.  Forward-looking statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ from those reflected in the forward-looking statements including as a result of changes in the general economic and political environment, changes in applicable legislation and the performance of each fund. There are no assurances the funds can fulfill such forward-looking statements and the funds do not undertake any obligation to update such statements. Such forward-looking statements are only predictions; actual events or results may differ materially as a result of risks facing one or more of the funds, some of which are beyond the control of the funds.

SOURCE Globalance Dividend Growers Corp.


These press releases may also interest you

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") and certain officers. The class action, filed in the United States District Court for the Southern District of...

at 11:00
The Georgia Trust for Historic Preservation presented 26 awards recognizing the best of preservation in Georgia during its 47th annual Preservation Awards ceremony in Athens, Ga. Security Federal Bank in Augusta received the Marguerite Williams...

at 11:00
Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against VinFast Auto Ltd. ("VinFast" or the "Company") f/k/a Black Spade Acquisition Co., ("Black Spade") and certain officers. The class action, filed in the United States District...

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against Ocugen, Inc. ("Ocugen" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext....

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") and certain officers.  The class action, filed in the United States District Court for the Southern District of...



News published on and distributed by: